Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Emmy M Dolman

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|February 10, 2015
Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenateM Emmy M Dolman, Ellen M Westerhout, Mohamed Hamdi, et al.
Plos One|December 31, 2015
DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma CellsM Emmy M Dolman, Ida van der Ploeg, Jan Koster, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 2, 2013
Liquid chromatography-tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasmaM Emmy M Dolman, Ilona J M den Hartog, Jan J Molenaar, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 13, 2014
Liquid chromatography-tandem mass spectrometric assay for the light sensitive survivin suppressant sepantronium bromide (YM155) in mouse plasmaM Emmy M Dolman, Ilona J M den Hartog, Jan J Molenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activityLaurel T Bate-Eya, Hinco J Gierman, Marli E Ebus, et al.
Bioconjugate Chemistry|March 30, 2011
Development of a cell-selective and intrinsically active multikinase inhibitor bioconjugateStefan Harmsen, M Emmy M Dolman, Zoltan Nemes, et al.
British Journal of Haematology|June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemiaPatrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2020
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responsesNil A Schubert, Linda Schild, Stijn van Oirschot, et al.
European Journal of Pharmacology|September 12, 2012
Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejectionFariba Poosti, Saleh Yazdani, M Emmy M Dolman, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical and Biomedical Analysis|February 10, 2015
Liquid chromatography-tandem mass spectrometric assay for the PI3K/mTOR inhibitor GSK2126458 in mouse plasma and tumor homogenateM Emmy M Dolman, Ellen M Westerhout, Mohamed Hamdi, et al.
Plos One|December 31, 2015
DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma CellsM Emmy M Dolman, Ida van der Ploeg, Jan Koster, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 2, 2013
Liquid chromatography-tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasmaM Emmy M Dolman, Ilona J M den Hartog, Jan J Molenaar, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 13, 2014
Liquid chromatography-tandem mass spectrometric assay for the light sensitive survivin suppressant sepantronium bromide (YM155) in mouse plasmaM Emmy M Dolman, Ilona J M den Hartog, Jan J Molenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activityLaurel T Bate-Eya, Hinco J Gierman, Marli E Ebus, et al.
Bioconjugate Chemistry|March 30, 2011
Development of a cell-selective and intrinsically active multikinase inhibitor bioconjugateStefan Harmsen, M Emmy M Dolman, Zoltan Nemes, et al.
British Journal of Haematology|June 4, 2026
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemiaPatrick Connerty, John N Colgan, Fatima El-Najjar, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2020
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responsesNil A Schubert, Linda Schild, Stijn van Oirschot, et al.
European Journal of Pharmacology|September 12, 2012
Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejectionFariba Poosti, Saleh Yazdani, M Emmy M Dolman, et al.
Pageof 4